This inventor holds 20 USPTO granted patents and 19 published patent applications and 2 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Novartis Ag, University of Pennsylvania, Harbour Biomed (Shanghai) Co., Ltd. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
14 out of 3,978 
7 out of 2,663 
2 out of 4 Years Active: 2017-2026
Areas of Expertise:
Title: Yongqiang Wang: Innovator in Antibody Development
Introduction
Yongqiang Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies for cancer treatment. With a total of 20 patents to his name, Wang's work has the potential to impact therapeutic strategies for various cancers.
Latest Patents
Wang's latest patents include groundbreaking inventions such as CLDN18.2-targeting antibodies and bispecific antibodies. The CLDN18.2-targeting antibody is a single-domain heavy-chain antibody that exhibits high affinity for tumor cells expressing CLDN18.2, inducing significant endocytic activity. Additionally, the bispecific antibody targets both CLDN18.2 and CD3, optimizing the CD3-terminus activity to reduce the release of common cytokines associated with cytokine release syndrome (CRS), such as IL6 and TNFα. Another notable invention focuses on the treatment of cancer using humanized anti-BCMA chimeric antigen receptor (CAR). This invention provides methods for treating diseases linked to BCMA expression, including compositions and methods for administering genetically modified T cells that express a CAR with a BCMA binding domain.
Career Highlights
Throughout his career, Yongqiang Wang has worked with esteemed organizations such as Novartis and the University of Pennsylvania. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research in antibody development.
Collaborations
Wang has collaborated with notable colleagues, including Qilong Wu and Jennifer Brogdon. These partnerships have further enhanced his research capabilities and expanded the impact of his inventions.
Conclusion
Yongqiang Wang's innovative work in antibody development showcases his commitment to advancing cancer treatment. His contributions through numerous patents highlight his role as a leading inventor in the biotechnology field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile